Your browser doesn't support javascript.
loading
Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID-19 in the Omicron variant era: A national cohort study in Iran.
Jamaati, Hamidreza; Karimi, Saeed; Ghorbani, Fariba; Panahi, Yunes; Hosseini-Baharanchi, Fatemeh Sadat; Hajimoradi, Maryam; Malek, Rayka; Noorali, Sima; Mokhtari, Majid; Khoundabi, Batoul; Sadr, Makan; Mohamadnia, Abdolreza; Zahraei, Seyed Mohsen; Hashemian, Seyed MohammadReza; Dastan, Farzaneh; Mortaz, Esmaeil; Tayeri, Katayoun; Behtaj, Fatemeh; Vaezi, Hassan; Forouzanfar, Mohammad Mehdi; Shafaghi, Shadi.
Afiliação
  • Jamaati H; Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • Karimi S; Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ghorbani F; Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Panahi Y; Pharmacotherapy Department, Faculty of Pharmacy, Bagyattallah University of Medical Sciences, Tehran, Iran.
  • Hosseini-Baharanchi FS; Department of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
  • Hajimoradi M; Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Malek R; Department of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
  • Noorali S; Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mokhtari M; Department of Pulmonary and Critical Care Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Khoundabi B; Iran Helal Institute of Applied-Science and Technology, Research Center for Health Management in Mass Gathering, Red Crescent Society of the Islamic Republic of Iran, Tehran, Iran.
  • Sadr M; Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mohamadnia A; Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • Zahraei SM; Center for Communicable Disease Control, Ministry of Health and Medical Education, Tehran, Iran.
  • Hashemian SM; Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • Dastan F; Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • Mortaz E; Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Tayeri K; Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Behtaj F; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Vaezi H; Center for Communicable Disease Control, Ministry of Health and Medical Education, Tehran, Iran.
  • Forouzanfar MM; Deputy for Treatment, Ministry of Health and Medical Education, Tehran, Iran.
  • Shafaghi S; Hospital Management and Clinical Excellence Center, Deputy for Treatment, Ministry of Health and Medical Education, Tehran, Iran.
J Med Virol ; 95(3): e28607, 2023 03.
Article em En | MEDLINE | ID: mdl-36815507

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article